Broad Antiviral Activity and Crystal Structure of HIV-1 Fusion Inhibitor Sifuvirtide
Open Access
- 24 February 2012
- journal article
- Published by Elsevier BV
- Vol. 287 (9), 6788-6796
- https://doi.org/10.1074/jbc.m111.317883
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in ChinaPublished by Elsevier BV ,2011
- In Vitro Selection and Characterization of HIV-1 Variants with Increased Resistance to Sifuvirtide, a Novel HIV-1 Fusion InhibitorPublished by Elsevier BV ,2011
- The Prevalence of Transmitted Antiretroviral Drug Resistance in Treatment-Naive HIV-Infected Individuals in ChinaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobilityProceedings of the National Academy of Sciences of the United States of America, 2009
- MolProbity: all-atom structure validation for macromolecular crystallographyActa crystallographica. Section D, Structural biology, 2009
- Detailed Mechanistic Insights into HIV-1 Sensitivity to Three Generations of Fusion InhibitorsPublished by Elsevier BV ,2009
- Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strainsProceedings of the National Academy of Sciences of the United States of America, 2008
- Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virusProceedings of the National Academy of Sciences of the United States of America, 2007
- The structural biology of type I viral membrane fusionNature Reviews Molecular Cell Biology, 2003
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences of the United States of America, 1994